Thomas Hoover
Corporate Officer/Principal at MATINAS BIOPHARMA HOLDINGS, INC.
Net worth: - $ as of 2024-04-29
Profile
Thomas J.
Hoover is currently the Chief Business Officer at Matinas BioPharma Holdings, Inc. Prior to this, he worked as the VP-New Product Planning & Corporate Development at Sumitomo Pharma America, Inc. from 2016 to 2021.
He also held the position of Senior Vice President-Commercial Strategy at Millendo Therapeutics, Inc. from 2016 to 2020.
Hoover has an MBA from Kenan-Flagler Business School and an undergraduate degree from Harvard College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Thomas Hoover active positions
Companies | Position | Start |
---|---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | 2021-12-05 |
Former positions of Thomas Hoover
Companies | Position | End |
---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 2020-12-31 |
MILLENDO THERAPEUTICS | Corporate Officer/Principal | - |
Training of Thomas Hoover
Harvard College | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
Private companies | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
- Stock Market
- Insiders
- Thomas Hoover